PE20170305A1 - Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio - Google Patents

Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio

Info

Publication number
PE20170305A1
PE20170305A1 PE2016002763A PE2016002763A PE20170305A1 PE 20170305 A1 PE20170305 A1 PE 20170305A1 PE 2016002763 A PE2016002763 A PE 2016002763A PE 2016002763 A PE2016002763 A PE 2016002763A PE 20170305 A1 PE20170305 A1 PE 20170305A1
Authority
PE
Peru
Prior art keywords
paracetamol
celecoxib
treatment
inflammatory pain
synergistic combination
Prior art date
Application number
PE2016002763A
Other languages
English (en)
Inventor
Medellin Jorge Fernando Cantu
Original Assignee
More Pharma Corp S De R L De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52279400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20170305(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by More Pharma Corp S De R L De C V filed Critical More Pharma Corp S De R L De C V
Publication of PE20170305A1 publication Critical patent/PE20170305A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Se refiere a una combinacion farmaceutica sinergistica util para el tratamiento de dolor inflamatorio, caracterizada porque comprende entre 375 mg y 500 mg de paracetamol y entre 50 mg y 75 mg de celecoxib. Tambien se refiere a una composicion farmaceutica que lo comprende
PE2016002763A 2013-07-11 2014-07-11 Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio PE20170305A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2013/055710 WO2015004505A1 (es) 2013-07-11 2013-07-11 Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio

Publications (1)

Publication Number Publication Date
PE20170305A1 true PE20170305A1 (es) 2017-04-21

Family

ID=52279400

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2016000043A PE20160239A1 (es) 2013-07-11 2014-07-11 Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
PE2016002763A PE20170305A1 (es) 2013-07-11 2014-07-11 Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2016000043A PE20160239A1 (es) 2013-07-11 2014-07-11 Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio

Country Status (8)

Country Link
CL (1) CL2015003211A1 (es)
CR (1) CR20160021A (es)
CU (1) CU24440B1 (es)
DO (1) DOP2016000008A (es)
EC (1) ECSP16005679A (es)
MX (1) MX366118B (es)
PE (2) PE20160239A1 (es)
WO (2) WO2015004505A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11147780B2 (en) * 2020-02-24 2021-10-19 Algia Pharma, Llc Multidrug pain management package

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070251A1 (en) * 2002-02-19 2003-08-28 Adcock Ingram Limited Pharmaceutical combinations of cox-2 inhibitors and opiates
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents

Also Published As

Publication number Publication date
WO2015004634A2 (es) 2015-01-15
DOP2016000008A (es) 2016-03-15
CU24440B1 (es) 2019-09-04
CU20160002A7 (es) 2016-06-29
WO2015004505A1 (es) 2015-01-15
MX366118B (es) 2019-06-27
MX2015013911A (es) 2015-12-08
ECSP16005679A (es) 2017-08-31
CL2015003211A1 (es) 2016-04-29
PE20160239A1 (es) 2016-05-13
CR20160021A (es) 2016-04-08
WO2015004634A3 (es) 2015-04-09

Similar Documents

Publication Publication Date Title
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2016002516A1 (es) “compuestos derivados de espirociclo sustituidos, inhibidores atx; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer, inflamaciones, dolor neuropático, enfermedades fibróticas, trombosis, entre otros”. pct
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
MY196173A (en) Cot Modulators And Methods Of Use Thereof
CL2018000222A1 (es) Nueva combinación para el uso en el tratamiento del cáncer
CL2015002658A1 (es) Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio
CL2016001547A1 (es) Composiciones para el cuidado oral
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
GT201700138A (es) Pirazolpiridinaminas
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
WO2014153009A3 (en) Thiosaccharide mucolytic agents
CL2016001546A1 (es) Composición para el cuidado oral que comprende serina y al menos una sal de zinc.
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
CL2016001350A1 (es) Composiciones de ketoprofeno de accion prologanda.
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
CL2015002188A1 (es) Agentes analgésicos oculares tópicos
PE20170305A1 (es) Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
CL2016002655A1 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
CL2016001054A1 (es) Compuestos para el tratamiento de diabetes y complicaciones de enfermedades derivadas de la misma
BR112017014295A2 (pt) composição farmacêutica.
CO7170180A2 (es) Composición farmacéutica inyectable de dexketoprofeno y tramadol